Abstract:Abstract Background Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fiber, possess neuroactive properties. The present study aimed to explore whether SCFAs-butyrate can repress neuroinflammation and alleviate cognitive impairment via improving gut mucosal barrier function and mediating tryptophan metabolism in LDLR−/− mice. Methods LDLR−/− mice were fed an atherosclerotic diet with 1.25% cholesterol and 40% calories from fat and concomitantly treated by intragastric administration with either normal saline as model group or 400mg/kg/day sodium butyrate for 8 weeks. Results For gut barrier function, butyrate increased expression of tight junction protein, and inhibited intestinal inflammatory pathways by targeting the toll-like receptor 4 signaling and the nod-like receptors domain containing 3 (NLRP3) inflammasome. Subsequently, butyrate reduced not only the serum lipopolysaccharide level but also its capability to cross the blood-brain barrier, leading to the suppression of tau phosphorylation and the improvement of neuroinflammation by inhibiting the increase in reactive microglia and astrocytes, and blocking NLRP3 inflammasome activation in the cortex and hippocampus. Final behavioral tests indicated that butyrate delayed cognitive impairment via decreasing latency to the platform and lengthening swimming distance in the target quadrant. Nevertheless, butyrate showed no effect on serotonin, indoleacetic acid, L-kynurenine, niacinamide, and their metabolites, indicating that the observed effects on cognitive function are unrelated to the tryptophan metabolism. Conclusion In summary, the present study provided the novel experimental evidence that butyrate played a neuroprotective role by targeting the NLRP3 inflammasome. The reduction of neuroinflammation may be related to the improvement of gut mucosal barrier function and the decrease of the penetration of intestinal endotoxin from the gut to the central nervous system.

Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4

Akkermansia and the microbial metabolites butyric acid and deoxycholic acid play key roles in fecal microbiota transplantation for the treatment of campylobacteriosis in mice

Clostridium butyricum Reduces Obesity in a Butyrate-Independent Way

Butyrate-producing bacteria as probiotic supplement: beneficial effects on metabolism and modulation of behaviour in an obesity mouse model

Effect of exercise and butyrate supplementation on microbiota composition and lipid metabolism.

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Supplementation With Sodium Butyrate Modulates The Composition Of The Gut Microbiota And Ameliorates High-Fat Diet-Induced Obesity In Mice

Butyrate Alleviates Cognitive Impairment by Improving Gut Mucosal Barrier Function and Blocking Neuroinflammatory Signaling in LDLR-/- Mice

Modulation of Gut Microbiota During Probiotic-Mediated Attenuation of Metabolic Syndrome in High Fat Diet-Fed Mice

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

Gut commensal-derived butyrate reverses obesity-induced social deficits and anxiety-like behaviors via regulation of microglial homeostasis

Clostridium butyricum Strain CCFM1299 Reduces Obesity via Increasing Energy Expenditure and Modulating Host Bile Acid Metabolism

P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation

Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice

Genes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide

Different Short-Chain Fatty Acids Unequally Modulate Intestinal Homeostasis and Reverse Obesity-Related Symptoms in Lead-Exposed High-Fat Diet Mice

Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels

Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis

Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice

Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice